Piedmont Investment Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,228
| Closed | -$200K | – | 924 |
|
|
2019
Q3 | $200K | Sell |
3,228
-760
| -19% | -$47.1K | 0.01% | 875 |
|
|
2019
Q2 | $284K | Buy |
+3,988
| New | +$284K | 0.01% | 788 |
|
|
2018
Q4 | – | Sell |
-7,775
| Closed | -$1.33M | – | 1065 |
|
|
2018
Q3 | $1.33M | Sell |
7,775
-177
| -2% | -$30.3K | 0.06% | 258 |
|
|
2018
Q2 | $1.03M | Buy |
7,952
+721
| +10% | +$93.2K | 0.05% | 303 |
|
|
2018
Q1 | $745K | Buy |
7,231
+279
| +4% | +$28.7K | 0.02% | 342 |
|
|
2017
Q4 | $594K | Sell |
6,952
-351
| -5% | -$30K | 0.01% | 372 |
|
|
2017
Q3 | $620K | Buy |
7,303
+705
| +11% | +$59.9K | 0.01% | 368 |
|
|
2017
Q2 | $500K | Buy |
+6,598
| New | +$500K | 0.01% | 418 |
|